AdaptHealth (NASDAQ:AHCO) Raised to “Buy” at Jefferies Financial Group

AdaptHealth (NASDAQ:AHCO) was upgraded by stock analysts at Jefferies Financial Group from a “hold” rating to a “buy” rating in a report released on Tuesday, Marketbeat.com reports. The brokerage presently has a $13.00 target price on the stock, up from their prior target price of $11.00. Jefferies Financial Group’s price target points to a potential upside of 19.49% from the stock’s previous close.

Other equities research analysts have also recently issued research reports about the stock. Wall Street Zen upgraded shares of AdaptHealth from a “hold” rating to a “buy” rating in a research note on Sunday, June 14th. Weiss Ratings restated a “sell (d)” rating on shares of AdaptHealth in a research report on Friday, May 22nd. UBS Group cut their price target on shares of AdaptHealth from $15.00 to $14.00 and set a “buy” rating for the company in a report on Wednesday, May 6th. Canaccord Genuity Group increased their price target on shares of AdaptHealth from $14.00 to $16.00 and gave the stock a “buy” rating in a research report on Wednesday, May 6th. Finally, Royal Bank Of Canada lifted their price objective on shares of AdaptHealth from $13.00 to $15.00 and gave the company an “outperform” rating in a research note on Monday, May 11th. Seven analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, AdaptHealth currently has an average rating of “Moderate Buy” and an average price target of $14.14.

AdaptHealth Stock Down 2.9%

Shares of NASDAQ AHCO opened at $10.88 on Tuesday. The company has a debt-to-equity ratio of 1.21, a quick ratio of 0.71 and a current ratio of 0.92. AdaptHealth has a 52 week low of $8.51 and a 52 week high of $13.43. The stock has a market capitalization of $1.48 billion, a P/E ratio of -17.55, a PEG ratio of 0.57 and a beta of 1.45. The stock’s fifty day moving average is $10.25 and its 200 day moving average is $10.65.

Insider Buying and Selling at AdaptHealth

In related news, insider Russell E. Schuster III sold 11,275 shares of the firm’s stock in a transaction on Monday, June 1st. The stock was sold at an average price of $10.06, for a total transaction of $113,426.50. Following the sale, the insider owned 136,538 shares of the company’s stock, valued at $1,373,572.28. This trade represents a 7.63% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.95% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On AdaptHealth

Several large investors have recently bought and sold shares of AHCO. Vanguard Group Inc. grew its holdings in shares of AdaptHealth by 4.4% during the fourth quarter. Vanguard Group Inc. now owns 11,768,599 shares of the company’s stock worth $117,215,000 after purchasing an additional 491,106 shares during the last quarter. Deerfield Management Company L.P. raised its holdings in AdaptHealth by 15.9% in the 3rd quarter. Deerfield Management Company L.P. now owns 11,477,730 shares of the company’s stock valued at $102,726,000 after buying an additional 1,572,835 shares during the last quarter. Reinhart Partners LLC. raised its holdings in AdaptHealth by 10.6% in the 4th quarter. Reinhart Partners LLC. now owns 8,100,785 shares of the company’s stock valued at $80,684,000 after buying an additional 773,727 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in AdaptHealth by 8.1% during the 1st quarter. Dimensional Fund Advisors LP now owns 6,920,973 shares of the company’s stock worth $82,353,000 after buying an additional 518,274 shares during the period. Finally, Principal Financial Group Inc. boosted its position in AdaptHealth by 25.1% during the 1st quarter. Principal Financial Group Inc. now owns 2,784,316 shares of the company’s stock worth $33,133,000 after buying an additional 558,357 shares during the period. 82.67% of the stock is currently owned by institutional investors.

About AdaptHealth

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.